By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Antithyroid agents > Thyrosafe > Potassium Iodide Dosage
Antithyroid agents
https://themeditary.com/dosage-information/potassium-iodide-dosage-8949.html

Potassium Iodide Dosage

Drug Detail:Thyrosafe (Potassium iodide [ poe-tah-see-um-eye-oh-dide ])

Drug Class: Antithyroid agents Expectorants

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Cough

300 to 600 mg diluted in a glass of water, fruit juice or milk orally 3 to 4 times a day

Comments:

  • This drug should be used no longer than necessary to produce desired effect.

Uses: As an expectorant in the symptomatic treatment of chronic pulmonary diseases where tenacious mucus complicates the problem, including bronchial asthma, bronchitis and pulmonary emphysema.

Usual Adult Dose for Radiation Emergency

130 mg orally once

Comments:

  • In the event of a nuclear radiation emergency, take as directed by public officials; take first dose as soon as possible.
  • Repeat doses may be needed in the event of prolonged exposure; since each dose provides up to 24 hours protection, repeat doses should be taken no sooner than 24 hours after prior dose.

Use: As a thyroid blocking agent during a nuclear radiation emergency.

Usual Pediatric Dose for Radiation Emergency

Birth to 1 month: 16.25 mg orally once
Over 1 month to 3 years: 32.5 mg orally once
Over 3 months to 12 years: 65 mg orally once
Over 12 years; weight less than 150 pounds (68.18 kg): 65 mg orally once
Over 12 years; weight 150 pounds (68.18 kg) or greater: 130 mg orally once

Comments:

  • In the event of a nuclear radiation emergency, take as directed by public officials; take first dose as soon as possible.
  • Repeat doses may be needed in the event of prolonged exposure; since each dose provides up to 24 hours protection, repeat doses should be taken no sooner than 24 hours after prior dose.

Use: As a thyroid blocking agent during a nuclear radiation emergency.

Renal Dose Adjustments

Use with caution

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

  • Hypersensitivity to iodine preparations or any product excipients

Safety and efficacy for use as an expectorant have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

SSKI (potassium iodide oral solution):

  • Dilute in 8 ounces water, fruit juice, or milk
  • To minimize gastric irritation, take with food or milk

ThyroShield 65 mg/mL:
  • Use with supplied dropper to accurately measure dose

Iostat Tablets:
  • Tablets may be taken whole or crushed
  • To create a liquid mixture yielding 3.25 mg/mL: Grind 130 mg tablet into fine powder and mix with 20 mL of water until dissolved, further dilute with 20 mL liquid (i.e., low fat white or chocolate milk, orange juice, flat soda, raspberry syrup, or infant formula); store in refrigerator; discard after 7 days

Storage requirements:
SSKI: Protect from light, keep tightly closed
  • When exposed to cold temperatures, may crystallize; with warming and shaking, crystals will dissolve; if solution turns brownish-yellow, it should be discarded
ThyroShield Oral Solution: Protect from light, keep tightly closed

General:
  • Potassium Iodide may be abbreviated KI on labeling.
  • In the event of a radiation emergency, public officials will provide instruction on when and for how long to take this drug.
  • In some patients, prolonged use of iodides can lead to hypothyroidism; iodides should be used with caution in patients with Addison's disease, cardiac disease, hyperthyroidism, myotonia congenita, tuberculosis, acute bronchitis, or renal function impairment.

Monitoring:
  • Monitor at risk patients for hypothyroidism; for neonates receiving this drug in the first few weeks of life, TSH and if necessary, T4 should be monitored

Patient advice:
  • Patients should be instructed to read the approved patient labeling.
  • Patients should seek direction from public officials in the event of a radiation emergency.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by